Fierce Pharma publisher Rebecca Willumson caught up with ixlayer’s General Manager of Biopharma, Matthew Walsh, at Digital Pharma East 2024 for a quick interview about the current and future state of pharma marketing.
In Case You Missed It: Key Takeaways from the 2025 ixlayer Client Advisory Meeting In early March, ixlayer hosted an engaging and insightful Client Advisory Meeting, bringing together industry leaders,
Pharma’s Role in Improving the Health Experience: Understanding Patient Expectations Patients have become accustomed to digital health, but they struggle with fragmented experiences. Patients want integrated solutions that make it
ixlayer and Ipsos’ “ixInsights 2025” Study Reveals Consumer Expectations for Digital Health and Pharma’s Role in Enhancing Patient Experience Study Captures Drivers and Deterrents to Digital Health to Inform Biopharma
Key Takeaways from Exploring Best Practices for Biopharma DTP Implementation – Part 2 ixlayer’s recent webinar in collaboration with The DHC Group, Exploring Best Practices for Biopharma DTP Implementation, clarifies
IX Layer Inc.
447 Sutter Street, Suite 405, PMB 53
San Francisco, CA 94108
IX Layer Inc.
222 Broadway, 22nd Floor
New York, NY 10038
